echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tasly Compound Danshen Dripping Pills Obtained the Notice of Approval of Drug Supplementary Application

    Tasly Compound Danshen Dripping Pills Obtained the Notice of Approval of Drug Supplementary Application

    • Last Update: 2021-10-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 12, Tasly issued an announcement stating that the company received the "Drug Supplementary Application Approval Notice" for compound Danshen dripping pills approved and issued by the State Food and Drug Administration.


    Fufang Danshen Dripping Pills is a compound Chinese medicine for the treatment of cardiovascular diseases developed exclusively by Tasly.


    In 2008, the company submitted a clinical supplementary application (acceptance number: CYZB0803905) for the compound Danshen dripping pill to increase the indications of diabetic retinopathy to the Drug Evaluation Center of the State Food and Drug Administration.


    Diabetic retinopathy is an eye disease characterized by retinal microvascular damage caused by diabetes.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.